Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ROCHE-HOLDING-AG-9364975/news/Roche-provides-update-on-the-phase-III-REMDACTA-trial-of-Actemra-RoActemra-plus-Veklury-in-patient-32656953/?utm_source=whatsapp&utm_medium=social&utm_campaign=share